Merck Canada Inc. reported 2 lobbying communications with federal officials between May 5, 2026 and Jul 2, 2026.
Officials contacted: Carlos Vanderloo (Counsellor Economic & Trade Policy); Kaitlyn Pritchard (Trade Program Manager Innovation and Industrial Policy); Kayla Slobodnik (Counsellor and Trade Commissioner); Mark Wiseman (Ambassador of Canada to the United States).
On the agenda: Any and all free trade treaty agreements as it relates to the North American Free Trade Agreement (NAFTA) and trade negotiations between Canada as it relates to the European Union, India, Japan and the Trans-Pacific Partnership.
International trade policies in support of the biopharmaceutical industry, including competitive and predictable intellectual property protection, product regulation and patient access to medicines; Policy measures to ensure security of drug supply in Canada and preserve Canada�s attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations; Pharmaceutical pricing policy issues arising from the jurisdiction of the Patended Medicines Prices Review Board (PMPRB) and R&D reporting.
